the brink's co. - BCO
BCO
Close Chg Chg %
87.03 2.65 3.04%
Closed Market
89.68
+2.65 (3.04%)
Volume: 282.30K
Last Updated:
Apr 22, 2025, 3:59 PM EDT
Company Overview: the brink's co. - BCO
BCO Key Data
| Open $88.30 | Day Range 87.87 - 90.23 |
| 52 Week Range 80.21 - 115.91 | Market Cap $3.76B |
| Shares Outstanding 43.20M | Public Float 42.79M |
| Beta 1.27 | Rev. Per Employee N/A |
| P/E Ratio 23.92 | EPS $3.67 |
| Yield 111.51% | Dividend $0.24 |
| EX-DIVIDEND DATE Feb 3, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 375.03K |
BCO Performance
| 1 Week | 2.48% | ||
| 1 Month | 7.01% | ||
| 3 Months | -3.90% | ||
| 1 Year | 1.10% | ||
| 5 Years | 103.29% |
BCO Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
3
Full Ratings ➔
About the brink's co. - BCO
The Brink's Co. engages in providing cash management services, digital retail solutions, and ATM managed services. It operates through the following geographical segments: North America, Latin America, Europe, and Rest of World. The North America segment operates in the U.S. and Canada. The Latin America segment refers to the operations in Latin American countries. The Europe segment relates to operations in European countries. The Rest of World segment focuses on the operations in the Middle East, Africa, and Asia. The company was founded by Perry Brink and Fidelia Brink on May 5, 1859 and is headquartered in Richmond, VA.
BCO At a Glance
The Brink's Co.
1801 Bayberry Court
Richmond, Virginia 23226-8100
| Phone | 1-804-289-9600 | Revenue | 5.01B | |
| Industry | Miscellaneous Commercial Services | Net Income | 162.90M | |
| Sector | Commercial Services | 2024 Sales Growth | 2.817% | |
| Fiscal Year-end | 12 / 2025 | Employees | 68,100 | |
| View SEC Filings |
BCO Valuation
| P/E Current | 23.923 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 25.513 |
| Price to Sales Ratio | 0.829 |
| Price to Book Ratio | 21.524 |
| Price to Cash Flow Ratio | 9.756 |
| Enterprise Value to EBITDA | 9.231 |
| Enterprise Value to Sales | 1.336 |
| Total Debt to Enterprise Value | 0.635 |
BCO Efficiency
| Revenue/Employee | 73,596.182 |
| Income Per Employee | 2,392.07 |
| Receivables Turnover | 6.679 |
| Total Asset Turnover | 0.758 |
BCO Liquidity
| Current Ratio | 1.521 |
| Quick Ratio | 1.521 |
| Cash Ratio | 0.969 |
BCO Profitability
| Gross Margin | 25.316 |
| Operating Margin | 8.621 |
| Pretax Margin | 5.313 |
| Net Margin | 3.25 |
| Return on Assets | 2.447 |
| Return on Equity | 55.573 |
| Return on Total Capital | 3.646 |
| Return on Invested Capital | 4.048 |
BCO Capital Structure
| Total Debt to Total Equity | 2,300.162 |
| Total Debt to Total Capital | 95.834 |
| Total Debt to Total Assets | 64.215 |
| Long-Term Debt to Equity | 2,100.487 |
| Long-Term Debt to Total Capital | 87.514 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for The Brink's Co. - BCO
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 4.20B | 4.54B | 4.87B | 5.01B | |
Sales Growth
| +13.80% | +7.98% | +7.48% | +2.82% | |
Cost of Goods Sold (COGS) incl D&A
| 3.24B | 3.46B | 3.71B | 3.74B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 239.50M | 245.80M | 275.80M | 293.30M | |
Depreciation
| 191.80M | 193.80M | 218.00M | 235.00M | |
Amortization of Intangibles
| 47.70M | 52.00M | 57.80M | 58.30M | |
COGS Growth
| +12.46% | +6.99% | +7.08% | +0.97% | |
Gross Income
| 964.40M | 1.07B | 1.17B | 1.27B | |
Gross Income Growth
| +18.53% | +11.32% | +8.75% | +8.68% | |
Gross Profit Margin
| +22.96% | +23.67% | +23.95% | +25.32% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 563.80M | 637.60M | 664.10M | 831.20M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 563.80M | 637.60M | 664.10M | 831.20M | |
SGA Growth
| +19.86% | +13.09% | +4.16% | +25.16% | |
Other Operating Expense
| 3.90M | 4.10M | 9.40M | 5.50M | |
Unusual Expense
| 1.80M | 24.20M | 10.20M | 21.50M | |
EBIT after Unusual Expense
| 394.90M | 407.70M | 483.80M | 410.60M | |
Non Operating Income/Expense
| (58.30M) | (40.50M) | (19.90M) | 113.40M | |
Non-Operating Interest Income
| 12.10M | 23.60M | 36.30M | 48.90M | |
Equity in Earnings of Affiliates
| 1.10M | 2.10M | 2.80M | 3.00M | |
Interest Expense
| 101.10M | 141.10M | 228.10M | 257.70M | |
Interest Expense Growth
| +16.34% | +39.56% | +61.66% | +12.98% | |
Gross Interest Expense
| 101.10M | 141.10M | 228.10M | 257.70M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 235.50M | 226.20M | 235.80M | 266.30M | |
Pretax Income Growth
| +196.97% | -3.95% | +4.24% | +12.93% | |
Pretax Margin
| +5.61% | +4.99% | +4.84% | +5.31% | |
Income Tax
| 120.30M | 41.40M | 139.20M | 92.70M | |
Income Tax - Current - Domestic
| 1.40M | 4.40M | 6.70M | 4.40M | |
Income Tax - Current - Foreign
| 104.30M | 99.30M | 109.80M | 106.30M | |
Income Tax - Deferred - Domestic
| 8.90M | (59.40M) | 26.40M | (23.60M) | |
Income Tax - Deferred - Foreign
| 5.70M | (2.90M) | (3.70M) | 5.60M | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| 1.10M | 2.10M | 2.80M | 3.00M | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 115.20M | 184.80M | 96.60M | 173.60M | |
Minority Interest Expense
| 12.10M | 11.30M | 10.60M | 11.80M | |
Net Income
| 103.10M | 173.50M | 86.00M | 161.80M | |
Net Income Growth
| +513.69% | +68.28% | -50.43% | +88.14% | |
Net Margin Growth
| +2.45% | +3.83% | +1.76% | +3.23% | |
Extraordinaries & Discontinued Operations
| 2.10M | (2.90M) | 1.70M | 1.10M | |
Discontinued Operations
| 2.10M | (2.90M) | 1.70M | 1.10M | |
Net Income After Extraordinaries
| 105.20M | 170.60M | 87.70M | 162.90M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 105.20M | 170.60M | 87.70M | 162.90M | |
EPS (Basic)
| 2.1252 | 3.6068 | 1.8983 | 3.6772 | |
EPS (Basic) Growth
| +569.35% | +69.72% | -47.37% | +93.71% | |
Basic Shares Outstanding
| 49.50M | 47.30M | 46.20M | 44.30M | |
EPS (Diluted)
| 2.0998 | 3.569 | 1.8699 | 3.6362 | |
EPS (Diluted) Growth
| +566.60% | +69.97% | -47.61% | +94.46% | |
Diluted Shares Outstanding
| 50.10M | 47.80M | 46.90M | 44.80M | |
EBITDA
| 636.20M | 677.70M | 769.80M | 725.40M | |
EBITDA Growth
| +16.65% | +6.52% | +13.59% | -5.77% | |
EBITDA Margin
| +15.15% | +14.94% | +15.79% | +14.47% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 125.00 | |
| Number of Ratings | 3 | Current Quarters Estimate | 1.623 | |
| FY Report Date | 06 / 2025 | Current Year's Estimate | 7.101 | |
| Last Quarter’s Earnings | 1.17 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 7.17 | Next Fiscal Year Estimate | 8.475 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 3 | 3 | 3 | 3 |
| Mean Estimate | 1.62 | 1.95 | 7.10 | 8.48 |
| High Estimates | 1.70 | 2.00 | 7.19 | 8.83 |
| Low Estimate | 1.55 | 1.87 | 7.03 | 8.07 |
| Coefficient of Variance | 4.60 | 3.73 | 1.15 | 4.55 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 3 | 3 | 3 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for The Brink's Co. - BCO
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for The Brink's Co. - BCO
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 21, 2025 | Richard M. Eubanks President and CEO; Director | 120,625 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $86.51 per share | 10,435,268.75 |
| Mar 6, 2025 | Richard M. Eubanks President and CEO; Director | 124,646 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Daniel J. Castillo EVP | 44,423 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $94.04 per share | 4,177,538.92 |
| Mar 6, 2025 | Daniel J. Castillo EVP | 48,750 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Daniel J. Castillo EVP | 48,157 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $88.51 per share | 4,262,376.07 |
| Mar 6, 2025 | Richard M. Eubanks President and CEO; Director | 12,070 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Richard M. Eubanks President and CEO; Director | 12,042 | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Mar 6, 2025 | Richard M. Eubanks President and CEO; Director | 10,593 | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Mar 6, 2025 | Richard M. Eubanks President and CEO; Director | 10,027 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Richard M. Eubanks President and CEO; Director | 121,361 | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Mar 6, 2025 | Richard M. Eubanks President and CEO; Director | 122,810 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $88.51 per share | 10,869,913.10 |
| Mar 6, 2025 | Paul Gerard Boynton Director | 9,617 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Richard M. Eubanks President and CEO; Director | 105,376 | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Mar 6, 2025 | Richard M. Eubanks President and CEO; Director | 105,942 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $94.04 per share | 9,962,785.68 |
| Mar 6, 2025 | Kurt B. McMaken EVP, Chief Financial Officer | 2,958 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Kurt B. McMaken EVP, Chief Financial Officer | 2,950 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Kurt B. McMaken EVP, Chief Financial Officer | 56,120 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $88.51 per share | 4,967,181.20 |
| Mar 6, 2025 | Kurt B. McMaken EVP, Chief Financial Officer | 56,706 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Kurt B. McMaken EVP, Chief Financial Officer | 51,514 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $94.04 per share | 4,844,376.56 |
| Mar 6, 2025 | Paul Gerard Boynton Director | 4,836 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |